Non-coding/regulatory variant interpretation — GWAS association lookup, eQTL evidence (GTEx), chromatin state (ENCODE), regulatory variant scoring (RegulomeDB, CADD), and TF-binding disruption. Use for non-coding GWAS hit interpretation, eQTL-based gene assignment, and regulatory mechanism reasoning. Distinct from coding-variant tools.
Installer avec Codex ou Claude Copiez ce prompt, collez-le dans Codex, Claude ou un autre assistant, puis laissez-le vérifier la page du skill et l'installer pour vous.
Une commande directe contourne le prompt de vérification. Examinez la source avant de l'exécuter.
Non-coding/regulatory variant interpretation — GWAS association lookup, eQTL evidence (GTEx), chromatin state (ENCODE), regulatory variant scoring (RegulomeDB, CADD), and TF-binding disruption. Use for non-coding GWAS hit interpretation, eQTL-based gene assignment, and regulatory mechanism reasoning. Distinct from coding-variant tools.
disable-model-invocation
true
COMPUTE, DON'T DESCRIBE
When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it.
Regulatory Variant Analysis Skill
Systematic regulatory variant interpretation: discover trait associations from GWAS, map eQTL effects, annotate chromatin context, assess regulatory element overlap, and produce evidence-graded functional impact predictions for non-coding variants.
When to Use
"What GWAS associations exist for rs12913832?"
"Find eQTLs for the APOE locus in brain tissue"
"What regulatory elements overlap this variant region?"
"Which SNPs are associated with type 2 diabetes from GWAS?"
"Is this intronic variant in an active enhancer?"
"What is the RegulomeDB score for rs429358?"
"Find ENCODE histone marks at the BRCA1 promoter region"
"Map trait ontology terms for 'blood pressure' to EFO IDs"
NOT for (use other skills instead):
Coding variant pathogenicity -> Use tooluniverse-variant-interpretation
Full clinical variant classification (ACMG) -> Use
tooluniverse-variant-interpretation
Gene-disease associations (not variant-specific) -> Use tooluniverse-gene-disease-association
Pharmacogenomic variant annotation -> Use tooluniverse-pharmacogenomics
Epigenomics data processing (BED/narrowPeak files) -> Use tooluniverse-epigenomics
Non-Coding Variant Impact Reasoning
When evaluating a non-coding variant, build evidence across four questions:
1. Is the variant in a regulatory element?
Use RegulomeDB to assess whether the variant overlaps TF binding sites, chromatin accessibility peaks, or known regulatory annotations. A low RegulomeDB score (categories 1a-2a) indicates strong evidence that the position is functionally active. Confirm with ENCODE histone marks: H3K27ac signals active enhancers and active promoters; H3K4me1 alone marks poised enhancers; H3K4me3 marks active promoters; H3K27me3 marks silenced regions.
2. Does it alter a transcription factor binding site?
Check RegulomeDB's TF binding evidence and ENCODE TF ChIP-seq experiments. A variant that falls within a TF footprint and disrupts the consensus motif is mechanistically actionable, especially if the TF is known to be relevant in the disease tissue.
3. Is there eQTL evidence linking it to a gene?
Query GTEx to determine whether the variant (or variants in tight LD) modulates expression of a nearby gene in a tissue-specific or ubiquitous manner. A tissue-specific eQTL suggests cell-type-specific regulation; a ubiquitous eQTL suggests a core regulatory element. The direction of the NES (positive = alternative allele increases expression, negative = decreases) and effect size matter for interpretation.
4. Is there GWAS evidence for trait association?
Search the GWAS Catalog for the rsID or the surrounding locus. Genome-wide significant associations (p < 5×10⁻⁸) in relevant traits anchor the variant's biological importance. Cross-reference with OpenTargets for locus-to-gene mapping from multiple GWAS studies.
Synthesizing the evidence: Build a multi-layer case. A variant with GWAS significance + eQTL evidence + RegulomeDB score 1a-2a + active chromatin (H3K27ac) in the relevant tissue represents high-confidence regulatory impact. Two or three converging lines of evidence (e.g., eQTL plus active enhancer) constitute moderate confidence. A single line, or a variant only in a poised but not active regulatory context, represents lower confidence.
Workflow Overview
Input (rsID, genomic coordinates, trait/disease, gene)
|
v
Phase 0: Variant/Trait Resolution
Resolve rsIDs, map trait names to EFO/MONDO IDs via OLS
|
v
Phase 1: GWAS Association Lookup
GWAS Catalog associations, p-values, effect sizes, study metadata
|
v
Phase 2: eQTL Analysis
GTEx tissue-specific eQTLs, target gene identification
|
v
Phase 3: Regulatory Element Annotation
ENCODE histone marks, RegulomeDB scores, chromatin state
|
v
Phase 4: OpenTargets GWAS Integration
OpenTargets GWAS study aggregation, locus-to-gene mapping
|
v
Phase 5: Functional Impact Synthesis
Integrate all evidence, assign regulatory impact level
|
v
Phase 6: Report
Evidence-graded regulatory variant report
Phase 0: Variant/Trait Resolution
Use ols_search_terms to resolve trait names to ontology IDs before GWAS queries. Restrict to ontology="efo" for GWAS traits; OpenTargets prefers MONDO IDs (e.g., MONDO_0005148 for type 2 diabetes rather than EFO_0001360). Use EnsemblVEP_annotate_rsid (param is variant_id, not rsid) for initial consequence annotation and nearest gene identification.
Phase 1: GWAS Association Lookup
gwas_search_associations is the primary tool: accepts disease_trait (free text), efo_id (preferred for precision), rs_id, and p_value threshold. Use p_value=5e-8 for genome-wide significance. For locus-level discovery, gwas_get_variants_for_trait retrieves all SNPs for a trait. gwas_get_snps_for_gene finds GWAS-cataloged SNPs mapped to a specific gene.
Reasoning tip: When GWAS Catalog returns empty for a free-text trait, switch to the efo_id parameter — the catalog uses controlled vocabulary and free-text matching is imprecise.
Phase 2: eQTL Analysis
GTEx_query_eqtl accepts a gene symbol (auto-resolved to GENCODE ID) or Ensembl gene ID. It returns tissue-specific SNP-gene associations with NES (normalized effect size) and p-value per tissue.
When interpreting results, ask: does the eQTL effect occur in the tissue most relevant to the disease? A brain-specific eQTL for a neurodegenerative disease variant is more compelling than a ubiquitous one. Use GTEx_get_median_gene_expression to confirm that the target gene is actually expressed in the relevant tissue before placing weight on eQTL evidence.
Note: GTEx API uses v8 data; gtex_v10 endpoints may return empty for some queries.
ENCODE_search_histone_experiments accepts histone_mark (e.g., "H3K27ac") and biosample_term_name (tissue or cell line name — NOT a disease name; ENCODE uses biological sample names like "liver" or "breast epithelium"). Use assay_title="TF ChIP-seq" (not just "ChIP-seq") when querying TF binding data.
Reasoning tip: RegulomeDB aggregates ENCODE, Roadmap, and other data. If ENCODE doesn't have the specific biosample, RegulomeDB may still have aggregate evidence from related cell types.
When you have the variant as a GRCh38 coordinate, FAVOR_annotate_variant(variant="chr-pos-ref-alt") returns a regulatory annotation block (plus conservation, frequency, and CADD) in one call — use it to quickly confirm whether the position falls in an annotated regulatory element before drilling into RegulomeDB/ENCODE.
Phase 4: OpenTargets GWAS Integration
OpenTargets_search_gwas_studies_by_disease takes diseaseIds as an array of MONDO IDs. It provides locus-to-gene (L2G) scores from multiple GWAS studies, which go beyond simple proximity to incorporate colocalisation, eQTL, and chromatin data. Use OpenTargets_multi_entity_search_by_query_string or OpenTargets_get_disease_id_description_by_name to resolve disease names to MONDO/EFO IDs first.
Phase 5: Functional Impact Synthesis
After collecting evidence, reason through the layers:
High impact: GWAS genome-wide significant + eQTL with meaningful NES + RegulomeDB score ≤ 2 + active chromatin (H3K27ac) in relevant tissue. Multiple independent lines converge on the same locus and gene.
Moderate impact: Two to three lines of evidence (e.g., eQTL + active enhancer overlap, or GWAS significant + RegulomeDB ≤ 3) without full convergence.
Low impact: Single line of evidence, or only computational annotation (VEP consequence category) without functional data.
No evidence: No regulatory annotations in any source; the variant may be in a non-functional region or the relevant cell type is not represented in available datasets.
Fallback Strategies
GWAS Catalog returns empty: Switch from free-text disease_trait to efo_id; broaden the trait term.
GTEx eQTL empty for gene: Verify gene symbol spelling; try Ensembl ID; increase size parameter.
RegulomeDB returns no data: Query ENCODE directly, or run FAVOR_annotate_variant (GRCh38 coordinate) for its regulatory + conservation annotation; the variant may lack regulatory annotations in available data.
OpenTargets GWAS returns None: Verify MONDO/EFO ID format; try OpenTargets_multi_entity_search_by_query_string first to confirm the correct ID.
ENCODE tissue not found: ENCODE uses specific biosample names; RegulomeDB aggregates data from many cell types and may cover the gap.
Step 1: EnsemblVEP_annotate_rsid(variant_id="rs12345678")
-> Confirm non-coding consequence, identify nearest gene
Step 2: RegulomeDB_query_variant(rsid="rs12345678")
-> Is this position in a regulatory context?
Step 3: gwas_search_associations(rs_id="rs12345678")
-> Any GWAS associations in relevant traits?
Step 4: GTEx_query_eqtl(gene_symbol=nearest_gene)
-> Does this variant or nearby variants modulate expression?
Step 5: ENCODE_search_histone_experiments(histone_mark="H3K27ac", biosample_term_name=relevant_tissue)
-> Active chromatin confirmation
Step 6: Classify impact based on convergence of evidence lines
Limitations
GWAS Catalog covers published GWAS only; unpublished studies are not included.
GTEx eQTL data is from v8; v10 endpoints may return empty.
RegulomeDB annotations depend on available ENCODE/Roadmap data for the specific cell type.
eQTL analysis identifies correlation, not causation; fine-mapping is needed to identify causal variants.
RegulomeDB scores are heuristic; a score of 1a does not guarantee functional impact.
GWAS associations are population-level; individual variant effects depend on genetic background.
